Cellebrite DI Ltd. Statistics
Share Statistics
Cellebrite DI Ltd. has 208.08M shares outstanding. The number of shares has increased by 5.43% in one year.
| Shares Outstanding | 208.08M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 1.36% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 86.02M |
| Failed to Deliver (FTD) Shares | 235 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 1.51M, so 0.73% of the outstanding shares have been sold short.
| Short Interest | 1.51M |
| Short % of Shares Out | 0.73% |
| Short % of Float | 1.76% |
| Short Ratio (days to cover) | 1.32 |
Valuation Ratios
The PE ratio is -20.31 and the forward PE ratio is 46.45.
| PE Ratio | -20.31 |
| Forward PE | 46.45 |
| PS Ratio | 5.07 |
| Forward PS | 9 |
| PB Ratio | 48.13 |
| P/FCF Ratio | 17.49 |
| PEG Ratio | n/a |
Enterprise Valuation
Cellebrite DI Ltd. has an Enterprise Value (EV) of 1.47B.
| EV / Earnings | -18.14 |
| EV / Sales | 4.53 |
| EV / EBITDA | -22.71 |
| EV / EBIT | 44.27 |
| EV / FCF | 15.63 |
Financial Position
The company has a current ratio of 1.66, with a Debt / Equity ratio of 0.
| Current Ratio | 1.66 |
| Quick Ratio | 1.62 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0 |
| Cash Flow / Debt | 0 |
| Interest Coverage | 235.72 |
Financial Efficiency
Return on equity (ROE) is -2.37% and return on capital (ROIC) is 73.79%.
| Return on Equity (ROE) | -2.37% |
| Return on Assets (ROA) | -0.15% |
| Return on Capital (ROIC) | 73.79% |
| Revenue Per Employee | 322.53K |
| Profits Per Employee | -80.46K |
| Employee Count | 1.01K |
| Asset Turnover | 0.61 |
| Inventory Turnover | 5.36 |
Taxes
| Income Tax | 5.54M |
| Effective Tax Rate | -0.07 |
Stock Price Statistics
The stock price has increased by 141.02% in the last 52 weeks. The beta is 1.5, so Cellebrite DI Ltd.'s price volatility has been higher than the market average.
| Beta | 1.5 |
| 52-Week Price Change | 141.02% |
| 50-Day Moving Average | 18.81 |
| 200-Day Moving Average | 14.36 |
| Relative Strength Index (RSI) | 54.39 |
| Average Volume (20 Days) | 1.31M |
Income Statement
In the last 12 months, Cellebrite DI Ltd. had revenue of $325.11M and earned -$81.10M in profits. Earnings per share was $-0.43.
| Revenue | 325.11M |
| Gross Profit | 271.88M |
| Operating Income | 33.24M |
| Net Income | -81.10M |
| EBITDA | -64.80M |
| EBIT | 33.24M |
| Earnings Per Share (EPS) | -0.43 |
Balance Sheet
The company has $189.52M in cash and $14.13M in debt, giving a net cash position of $175.39M.
| Cash & Cash Equivalents | 189.52M |
| Total Debt | 14.13M |
| Net Cash | 175.39M |
| Retained Earnings | 118.14M |
| Total Assets | 629.25M |
| Working Capital | 228.53M |
Cash Flow
In the last 12 months, operating cash flow was $102.06M and capital expenditures -$7.92M, giving a free cash flow of $94.14M.
| Operating Cash Flow | 102.06M |
| Capital Expenditures | -7.92M |
| Free Cash Flow | 94.14M |
| FCF Per Share | 0.5 |
Margins
Gross margin is 83.63%, with operating and profit margins of 10.22% and -24.95%.
| Gross Margin | 83.63% |
| Operating Margin | 10.22% |
| Pretax Margin | -23.24% |
| Profit Margin | -24.95% |
| EBITDA Margin | -19.93% |
| EBIT Margin | 10.22% |
| FCF Margin | 28.96% |
Dividends & Yields
CLBT does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -2.17% |
| FCF Yield | 2.28% |
Analyst Forecast
The average price target for CLBT is $21, which is 5.7% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21 |
| Price Target Difference | 5.7% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
Scores
| Altman Z-Score | 7.92 |
| Piotroski F-Score | 4 |